Deep Track Special Opportunities Fund, LP - 12 Sep 2025 Form 3 Insider Report for LB PHARMACEUTICALS INC

Reporting relationship: 10%+ Owner
Issuer ticker: LBRX on Nasdaq
Reported as of: 12 Sep 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 16 Sep 2025, 18:07:05 UTC
Source filing: View source filing
Reporting owner signature: Deep Track Special Opportunities Fund, LP, By David Kroin managing member of the Investment Manager

Key filing fact

Deep Track Special Opportunities Fund, LP filed Form 3 for LB PHARMACEUTICALS INC on 16 Sep 2025.

Key facts

This page summarizes Deep Track Special Opportunities Fund, LP's Form 3 filing for LB PHARMACEUTICALS INC.
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 16 Sep 2025, 18:07.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002077950 Primary reporting owner

Deep Track Special Opportunities Fund, LP

Relationship: 10%+ Owner
Address: 200 GREENWICH AVENUE, 3RD FLOOR, GREENWICH
Signature: Deep Track Special Opportunities Fund, LP, By David Kroin managing member of the Investment Manager
Signature date: 16 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LBRX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 666,666
Date: 12 Sep 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents securities held by Deep Track Special Opportunities Fund, LP. Deep Track Capital, LP is the investment manager of Deep Track Special Opportunities Fund, LP. Mr. David Kroin is the managing member of Deep Track Capital GP, LLC, the general partner of Deep Track Capital, LP., and by virtue of such status may be deemed to be the beneficial owner of the shares owned by Deep Track Special Opportunities Fund, LP. Affiliates of the Reporting Person, including Deep Track Biotechnology Master Fund, Ltd, Deep Track Capital, LP and Mr. Kroin, have separately filed Section 16 reports with respect to the shares of Issuer common stock they may be deemed to beneficially own.

SEC remarks

Affiliates of the Reporting Person beneficially own in the aggregate more than ten percent of the outstanding shares of Issuer common stock. Therefore, the Reporting Person may be deemed to be a ten percent owner with respect to Issuer securities.